1. Home
  2. PDYN vs ZNTL Comparison

PDYN vs ZNTL Comparison

Compare PDYN & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PDYN

Palladyne AI Corp.

HOLD

Current Price

$2.38

Market Cap

164.8M

Sector

Industrials

ML Signal

HOLD

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

HOLD

Current Price

$1.37

Market Cap

165.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDYN
ZNTL
Founded
1983
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.8M
165.1M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
PDYN
ZNTL
Price
$2.38
$1.37
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
★ $7.63
$7.44
AVG Volume (30 Days)
1.1M
★ 1.3M
Earning Date
11-10-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 108.86
18.03
EPS
★ N/A
N/A
Revenue
★ $5,246,000.00
N/A
Revenue This Year
$399.07
N/A
Revenue Next Year
$41.58
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.66
$1.30
52 Week High
$10.00
$6.95

Technical Indicators

Market Signals
Indicator
PDYN
ZNTL
Relative Strength Index (RSI) 26.38 23.27
Support Level N/A N/A
Resistance Level $6.80 $1.98
Average True Range (ATR) 0.36 0.18
MACD -0.02 -0.01
Stochastic Oscillator 2.13 8.82

Price Performance

Historical Comparison
PDYN
ZNTL

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: